1. Home
  2. PRT vs ELUT Comparison

PRT vs ELUT Comparison

Compare PRT & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PermRock Royalty Trust Trust Units

PRT

PermRock Royalty Trust Trust Units

HOLD

Current Price

$3.45

Market Cap

43.9M

Sector

Energy

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$1.10

Market Cap

50.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRT
ELUT
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.9M
50.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PRT
ELUT
Price
$3.45
$1.10
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
41.5K
172.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
12.47%
N/A
EPS Growth
N/A
10.14
EPS
N/A
N/A
Revenue
N/A
$24,375,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.61
$0.50
52 Week High
$4.42
$3.46

Technical Indicators

Market Signals
Indicator
PRT
ELUT
Relative Strength Index (RSI) 52.37 53.01
Support Level $3.28 $0.86
Resistance Level $4.09 $1.15
Average True Range (ATR) 0.13 0.14
MACD -0.00 -0.01
Stochastic Oscillator 60.00 13.24

Price Performance

Historical Comparison
PRT
ELUT

About PRT PermRock Royalty Trust Trust Units

PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: